Although it is not exactly understood how thrombocytopenia affects VEGF balance and phases of ROP, it is claimed that proliferative retinopathy occurs with an increase in endogenous production of IGF-1 by activation of retinal VEGF accumulation in ROP pathogenesis (second phase). The gene discussed is IGF1; the disease is retinal disorder.